US EditionKinney Drugs expands COVID-19 vaccine access for high-risk individuals
Summary by CDR – Chain Drug Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Kinney Drugs expands COVID-19 vaccine access for high-risk individuals
GOVERNEUR, N.Y. – Kinney Drugs has now opened both walk-ins and appointments for a second dose of seasonal COVID-19 vaccine for eligible individuals. In October, the CDC recommended that individuals aged 65 and older and those who are moderately to severely immunocompromised receive a second dose of seasonal COVID-19 vaccine two to six months after their last dose.Patients in one or both groups who were vaccinated against COVID in the fall may n…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
